Cancer, Renal Lymphoma

Article Author:
Maria Bokhari

Article Editor:
Syed Rizwan Bokhari

Editors In Chief:
Stephen Leslie
Karim Hamawy

Managing Editors:
Avais Raja
Orawan Chaigasame
Carrie Smith
Abdul Waheed
Khalid Alsayouri
Trevor Nezwek
Radia Jamil
Patrick Le
Anoosh Zafar Gondal
Saad Nazir
William Gossman
Hassam Zulfiqar
Steve Bhimji
John Shell
Matthew Varacallo
Heba Mahdy
Ahmad Malik
Sarosh Vaqar
Mark Pellegrini
James Hughes
Beata Beatty
Nazia Sadiq
Hajira Basit
Phillip Hynes
Tehmina Warsi

4/23/2019 7:22:57 PM


Renal involvement in lymphoma is commonly in the presence of widespread nodal or extranodal lymphoma. This is classified as secondary renal lymphoma (SRL). Rarely, lymphoma may involve the kidneys alone without evidence of disease elsewhere; this presentation is termed primary renal lymphoma (PRL). Although the diagnosis of renal lymphoma can be challenging, an awareness of the spectrum of imaging findings can help to differentiate lymphoma from other renal malignancies, such as renal cell carcinoma (RCC), and can lead to appropriate recommendations for biopsy. An accurate diagnosis is critical because renal lymphoma is treated by chemotherapy whereas RCC is typically managed by surgery or ablation.[1][2][3]Renal lymphoma is commonly secondary to lymphomatous infiltration of the kidneys in systemic disseminated lymphoma and advanced stage IV disease while renal lymphoma arising primarily in the renal parenchyma is a rarely described entity. Primary renal lymphoma comprises only 0.7% of extranodal lymphomas.[4][5]


Renal involvement in autopsy cases is secondary to non-Hodgkin disease in 30% to 60% of cases. Immunocompromised patients with uncontrolled Epstein-Barr virus proliferation, organ transplantation, patients undergoing chemotherapeutic therapy, patients with HIV infection, or ataxia-telangiectasia patients are at increased risk. Primary renal lymphoma is of Hodgkin-type arising in hilar nodes or renal parenchyma form only less than 1 % of renal lymphoma. Association of the tumor has been found with chronic inflammatory and infectious diseases like Sjogren, systemic lupus erythematosus, chronic pyelonephritis, and Epstein-Barr virus infections.[6][7]


While renal lymphoma has autopsy incidence of 30% to 60% in lymphoma patients, actual CT diagnosis incidence is approximately 5%. The kidneys are the most common abdominal organ affected by non-Hodgkin lymphoma. Involvement of the kidneys in primary renal lymphoma is rare (less than 1%). It is mostly seen in middle to advanced age. It forms about 0.7% of the extranodal lymphomas in North America. The bilateral presentation is seen in 10% to 20% of the cases.


The kidneys are the most common abdominal organ affected by systemic lymphoma according to several studies. Renal involvement is most common with B-cell lymphoma, and the majority are intermediate or high-grade lymphomas including Burkitt and histiocytic varieties. Gross macroscopy reveals fleshy or firm yellow, tan, or gray tumors that are 1 to 20 cm. The pathogenesis of primary renal lymphoma is dubious as the normal kidney does not have any lymphoid tissue. Puente Duanay hypothesized that pre-existing inflammatory processes recruit lymphoid cells into renal parenchyma and an untimely oncogenic event takes place to complete the multistep process of oncogenesis. The renal capsule is rich in lymphatics, and it has been suggested that the tumor penetrates the parenchyma from the capsule, subcapsular tissue, or the renal sinus with subsequent invasion of the renal parenchyma. Tumor proliferation initiates in the interstitium and the adjacent nephrons and collecting ducts, and blood vessels act as a framework for tumor growth. An infiltrative growth pattern results in preservation of the parenchymal structures and renal contour. Consequently, detection of renal involvement becomes difficult and can easily be missed on histopathology. As lymphomatous tumors enlarge, the surrounding renal parenchyma is compressed and displaced causing the formation of solitary or more commonly multiple nodular masses. Uneven infiltrative growth can result in extension beyond the renal capsule into the perinephric space, mimicking primary renal neoplasms. Continued growth may ultimately cause replacement of the whole renal parenchymal architecture.

History and Physical

Renal lymphoma is commonly seen as a part of the spectrum of multi-systemic; however, it may seldom be seen as a primary disease. It usually presents in middle-aged persons although half of the cases may be clinically silent. Presenting symptoms include flank pain, weight loss, fever, night sweats, palpable abdominal mass, hematuria, and deranged renal function usually seen as elevated serum creatinine.

Primary renal lymphoma is an infiltrative tumor that grows without disruption of structure or function. However, the most common presentation of primary renal lymphoma is acute renal failure, flank pain, and mass. The cause for renal failure is somewhat ambiguous, but several theories have been postulated including lymphomatous infiltration of the parenchyma, hypercalcemia due to vitamin D overproduction by the lymphomatous mass or ureteral, and vascular or tubular compression by the lesion.


Renal Function Studies

Laboratory studies to assess renal function include blood urea nitrogen (BUN) and creatinine. Although clinical evidence of renal involvement with lymphoma is only seen in 2% to 14 %of patients, an elevated serum creatinine is reported in 26% to 56%. An elevated BUN or creatinine level may indicate bilateral ureteral obstruction subsequent to massive retroperitoneal lymph nodes or as a adverse effect of nephrotoxic chemotherapeutic agents.[8][9][10]

Renal Biopsy

The diagnosis of primary renal lymphoma requires biopsy in most cases as imaging findings are nonspecific. Although fine-needle aspiration is a useful technique, core tissue biopsy with flow cytometry and immunohistochemical staining is recommended as it has a higher diagnostic accuracy according to several studies.

With regard to secondary renal lymphoma (SRL), renal biopsy is usually not required in the presence of disseminated disease. However, it is reported that patients with lymphoma have a higher incidence of renal cell carcinoma (RCC) than the general population. Differentiating SRL presenting as a solitary mass (typically hypovascular) from clear cell RCC (mostly hypervascular) on imaging may be straightforward. Nonetheless, other histologic subtypes of RCC, like papillary and chromophobe RCCs, can also appear hypovascular on imaging, making it harder to differentiate from SRL. In such cases, a renal biopsy may be validated.


There are several patterns of lymphomatous involvement of kidneys; the most common on imaging is multiple parenchymal nodular masses of variable size, typically 1 to 4.5 cm in diameter. This presentation is seen in approximately 50 to 60% of cases. The lesions are usually bilateral, but unilateral renal presentation can also be seen. The second most common pattern of involvement constitutes a contiguous extension to the kidneys or perinephric space from large retroperitoneal nodal masses (seen in 25% to 30% of cases).

Renal lymphoma presenting as a solitary mass is encountered in 10% to 25% of patients. On non-enhanced CT scan lymphomatous mass is slightly more hyperattenuating than the surrounding normal renal parenchyma. At contrast-enhanced CT, the mass is hypovascular and characteristically demonstrates minimal enhancement. This feature is invaluable in differentiating renal lymphoma from RCC, which mostly manifests moderate to avid enhancement in the arterial phase. Isolated perinephric lymphoma is rarely seen (less than 10% of cases). Contrast-enhanced CT scans are important for demonstrating a ring of homogeneous perinephric tissue which encases the normal parenchyma, with contrast-enhanced causing any significant renal dysfunction. Diffuse renal enlargement without distortion of the reniform shape of the kidneys or formation of any discrete masses presents in 6% to 19% of cases. Nephromegaly is almost always bilateral. If both kidneys are extensively infiltrated, acute renal failure. Contrast-enhanced CT demonstrates heterogeneous enhancement of the kidneys, loss of the normal corticomedullary differential enhancement, encasement and deformation of the pevicalyceal system, and infiltration of the renal sinus fat. Alternatively, the renal parenchyma is replaced by poorly defined low-attenuation lesions. The collecting system is encased and stretched instead of being displaced. The sonographic picture of infiltrative renal lymphoma is globular enlargement of the kidneys with heterogeneous echotexture and effacement of renal sinus.

Nuclear Imaging

Gallium-67 citrate has been used for diagnosing and staging lymphoma. This radioisotope concentrates in lymphoma. and is taken up by lymphomatous tissue in the kidneys. It also is concentrated in the inflammatory masses of the kidney. The degree of sensitivity increases in case of high grade lymphoma.18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) scanning has been commonly used for staging and follow-up after treatment. The use of another agent, technetium-99m (Tc)-labeled antibody (LL2), has been advocated in imaging and staging lymphomas, especially in cases of low-grade lymphoma.

Treatment / Management

Differentiating renal lymphoma from other renal masses is crucial as well as challenging, especially in cases of unilateral lesions that mimic renal carcinomas both radiologically as well as pathologically. The standard management of a renal mass is radial or partial nephrectomy. However, a patient with renal lymphoma is treated with systemic chemotherapy.

Surgery or systemic chemotherapy, with or without radiotherapy, is a widely-used treatment for primary renal lymphoma. The prognosis of patients affected by primary renal lymphoma is grave, despite the absence of disseminated disease. For bilateral renal lymphoma, systemic chemotherapy using a CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) regimen is the treatment of choice; this preserves the organ function, but the subsequent prognosis is poor because although chemotherapy usually improves the renal function. The few cases reported in the literature show increased mortality because of rapid relapse or infections occurring from neutropenia. Alternatively, bilateral nephrectomy invariably leads to the permanent need for hemodialysis. Overall survival rate and long-term disease-free interval are relatively better when surgery and chemotherapy are combined.

Enhancing Healthcare Team Outcomes

Lymphoma of the kidney may be primary or secondary, but in both cases making a diagnosis is not easy. The disorder is best managed by a multidisciplinary team that includes the pathologist, radiologist, urologist, oncologist, radiation specialist and a team of specialty nurses. To differentiate lymphoma from other renal cancers usually requires a biopsy. Once diagnosed, the treatment is chemotherapy plus radiation. The prognosis of these patients depend on whether the lymphoma is primary or secondary. With advances in treatment, most patients have improved survival but complications of therapy often can be life-threatening.[11][12]

  • Image 5537 Not availableImage 5537 Not available
    Contributed by Jinnah Hospital; Lahore, Pakistan
Attributed To: Contributed by Jinnah Hospital; Lahore, Pakistan

Interested in Participating?

We are looking for contributors to author, edit, and peer review our vast library of review articles and multiple choice questions. In as little as 2-3 hours you can make a significant contribution to your specialty. In return for a small amount of your time, you will receive free access to all content and you will be published as an author or editor in eBooks, apps, online CME/CE activities, and an online Learning Management System for students, teachers, and program directors that allows access to review materials in over 500 specialties.

Improve Content - Become an Author or Editor

This is an academic project designed to provide inexpensive peer-reviewed Apps, eBooks, and very soon an online CME/CE system to help students identify weaknesses and improve knowledge. We would like you to consider being an author or editor. Please click here to learn more. Thank you for you for your interest, the StatPearls Publishing Editorial Team.

Cancer, Renal Lymphoma - Questions

Take a quiz of the questions on this article.

Take Quiz
Which of the following is true with respect to renal lymphoma?

Click Your Answer Below

Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.

Sign Up
A 63-year-old male presents with complaints of severe fatigue. He reports worsening exercise tolerance and anorexia. He denies any history of blood loss. Physical exam shows enlarged cervical, inguinal, and supraclavicular lymph nodes. The abdomen is soft and non-tender with a mildly enlarged spleen. Imaging was consistent with bilaterally enlarged kidneys, measuring 13.5 cm and 12.9 cm each. His hemoglobin level is 6.8 mg/dl, MCV 87 fl/cell, BUN 56 mg/dl, and creatinine 1.5 mg/dl. Which of the following is the most likely cause of this patient's anemia?

Click Your Answer Below

Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.

Sign Up

Cancer, Renal Lymphoma - References


Li W,Sun Z, Mechanism of Action for HDAC Inhibitors-Insights from Omics Approaches. International journal of molecular sciences. 2019 Apr 1;     [PubMed]
Stanescu AL,Acharya PT,Lee EY,Phillips GS, Pediatric Renal Neoplasms:: MR Imaging-Based Practical Diagnostic Approach. Magnetic resonance imaging clinics of North America. 2019 May;     [PubMed]
Blas L,Roberti J,Petroni J,Reniero L,Cicora F, Renal Medullary Carcinoma: a Report of the Current Literature. Current urology reports. 2019 Jan 17;     [PubMed]
Gupta R,Amanam I,Rahmanuddin S,Mambetsariev I,Wang Y,Huang C,Reckamp K,Vora L,Salgia R, Anaplastic Lymphoma Kinase (ALK)-positive Tumors: Clinical, Radiographic and Molecular Profiles, and Uncommon Sites of Metastases in Patients With Lung Adenocarcinoma. American journal of clinical oncology. 2019 Apr;     [PubMed]
Velvet AJJ,Bhutani S,Papachristos S,Dwivedi R,Picton M,Augustine T,Morton M, A single-center experience of post-transplant lymphomas involving the central nervous system with a review of current literature. Oncotarget. 2019 Jan 11;     [PubMed]
Sakr HI,Buckley K,Baiocchi R,Zhao WJ,Hemminger JA, Erdheim Chester disease in a patient with Burkitt lymphoma: a case report and review of literature. Diagnostic pathology. 2018 Nov 24;     [PubMed]
Tsuchimoto A,Masutani K,Omoto K,Okumi M,Okabe Y,Nishiki T,Ota M,Nakano T,Tsuruya K,Kitazono T,Nakamura M,Ishida H,Tanabe K, Kidney transplantation for treatment of end-stage kidney disease after haematopoietic stem cell transplantation: case series and literature review. Clinical and experimental nephrology. 2019 Apr;     [PubMed]
Oda Y,Ishioka K,Ohtake T,Sato S,Tamai Y,Oki R,Matsui K,Mochida Y,Moriya H,Hidaka S,Kobayashi S, Intravascular lymphoma forming massive aortic tumors complicated with sarcoidosis and focal segmental glomerulosclerosis: a case report and literature review. BMC nephrology. 2018 Oct 29;     [PubMed]
Uppal NN,Monga D,Vernace MA,Mehtabdin K,Shah HH,Bijol V,Jhaveri KD, Kidney diseases associated with Waldenström macroglobulinemia. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2018 Oct 31;     [PubMed]
Ouyang ZZ,Peng TS,Cao QH,Ouyang Y,Li JX,Wei QX,Zhan H, T-cell lymphoma with rhabdomyolysis: case report and literature review. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas. 2018;     [PubMed]
Benoni H,Eloranta S,Ekbom A,Wilczek H,Smedby KE, Survival among solid organ transplant recipients diagnosed with cancer compared to nontransplanted cancer patients-A nationwide study. International journal of cancer. 2019 Mar 28;     [PubMed]
Mrdenovic S,Zhang Y,Wang R,Yin L,Chu GC,Yin L,Lewis M,Heffer M,Zhau HE,Chung LWK, Targeting Burkitt lymphoma with a tumor cell-specific heptamethine carbocyanine-cisplatin conjugate. Cancer. 2019 Mar 6;     [PubMed]


The intent of StatPearls is to provide practice questions and explanations to assist you in identifying and resolving knowledge deficits. These questions and explanations are not intended to be a source of the knowledge base of all of medicine, nor is it intended to be a board or certification review of Surgery-Urologic. The authors or editors do not warrant the information is complete or accurate. The reader is encouraged to verify each answer and explanation in several references. All drug indications and dosages should be verified before administration.

StatPearls offers the most comprehensive database of free multiple-choice questions with explanations and short review chapters ever developed. This system helps physicians, medical students, dentists, nurses, pharmacists, and allied health professionals identify education deficits and learn new concepts. StatPearls is not a board or certification review system for Surgery-Urologic, it is a learning system that you can use to help improve your knowledge base of medicine for life-long learning. StatPearls will help you identify your weaknesses so that when you are ready to study for a board or certification exam in Surgery-Urologic, you will already be prepared.

Our content is updated continuously through a multi-step peer review process that will help you be prepared and review for a thorough knowledge of Surgery-Urologic. When it is time for the Surgery-Urologic board and certification exam, you will already be ready. Besides online study quizzes, we also publish our peer-reviewed content in eBooks and mobile Apps. We also offer inexpensive CME/CE, so our content can be used to attain education credits while you study Surgery-Urologic.